$1.14
0[0.00%]
At close: Apr 18
$1.14
0[0.00%]
After Hours: 7:22PM EDT
Bolt Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bolt Biotherapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | BOLT | Q1 | -$0.45 | -$0.52 | — | — | $1.83M | $1.50M | — | — | Get Alert |
03/21/2024 | PM | BOLT | Q4 | -$0.53 | -$0.48 | -$0.47 | 2.08% | $1.41M | $1.71M | $2.09M | 22.16% | Get Alert |
11/09/2023 | PM | BOLT | Q3 | -$0.58 | -$0.50 | -$0.43 | 14.00% | $2.11M | $1.72M | $2.53M | 46.98% | Get Alert |
08/07/2023 | PM | BOLT | Q2 | -$0.61 | -$0.49 | -$0.48 | 2.04% | $1.39M | $1.90M | $1.43M | -24.58% | Get Alert |
05/11/2023 | PM | BOLT | Q1 | -$0.64 | -$0.51 | -$0.45 | 11.76% | $813.00K | $1.31M | $1.83M | 39.39% | Get Alert |
03/29/2023 | PM | BOLT | Q4 | -$0.73 | -$0.60 | -$0.53 | 11.67% | $508.00K | $1.23M | $1.41M | 14.72% | Get Alert |
11/10/2022 | PM | BOLT | Q3 | -$0.63 | -$0.56 | -$0.58 | -3.57% | $752.00K | $980.00K | $2.11M | 115.51% | Get Alert |
08/10/2022 | PM | BOLT | Q2 | -$0.64 | -$0.68 | -$0.61 | 10.29% | $0.00 | — | $1.39M | — | Get Alert |
05/12/2022 | PM | BOLT | Q1 | -$1.14 | — | -$0.64 | — | $0.00 | — | $813.00K | — | Get Alert |
03/30/2022 | PM | BOLT | Q4 | -$14.58 | -$0.82 | -$0.73 | 10.98% | $0.00 | $370.00K | $508.00K | 37.30% | Get Alert |
11/09/2021 | AM | BOLT | Q3 | — | -$0.66 | -$0.63 | 4.55% | — | $370.00K | $752.00K | 103.24% | Get Alert |
08/12/2021 | PM | BOLT | Q2 | — | -$0.43 | -$0.64 | -48.84% | — | $3.33M | $0.00 | -100.00% | Get Alert |
05/13/2021 | PM | BOLT | Q1 | -$4.16 | -$0.60 | -$1.14 | -90.00% | — | — | $0.00 | — | Get Alert |
03/31/2021 | PM | BOLT | Q4 | — | -$0.55 | -$14.58 | -2550.91% | — | — | $0.00 | — | Get Alert |
Bolt Biotherapeutics (BOLT) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 21, 2024 for Q4.
The Actual EPS was $-0.47, which beat the estimate of $-0.48.
The Actual Revenue was $2.1M, which beat the estimate of $1.7M.
Browse earnings estimates, EPS, and revenue on all stocks.